We identified novel (3R, 5S)-3-aminomethyl-5-methanesulfanyl hexanoic acid (5a: DS75091588) and (3R, 5S)-3-aminomethyl-5-ethanesulfanyl hexanoic acid (6a: DS18430756) as sulfur-containing γ-amino acid derivatives that were useful for the treatment of neuropathic pain. These two compounds exhibited a potent analgesic effect in animal models of both type I diabetes and type II diabetes, and good pharmacokinetics.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.bmcl.2018.05.006 | DOI Listing |
Publication Analysis
Top Keywords
hexanoic acid
8
type diabetes
8
alkylsulfanyl analogs
4
analogs potent
4
potent αδ
4
αδ ligands
4
ligands identified
4
identified novel
4
novel 5s-3-aminomethyl-5-methanesulfanyl
4
5s-3-aminomethyl-5-methanesulfanyl hexanoic
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!